One of the well known South Korean pharmaceutical company having a worth of $600+Mn consulted Freyr for the technical review of Batch Manufacturing Record (BMR) and quality by design protocol in accordance with the USFDA requirements in Regulatory aspects.

Check out the case to see how Freyr overcome all the challenges and completed the entire review and offered BMR in accordance with the USFDA.

Download